Russian PCR equipment maker DNA Technology plans first overseas factory in Uttar Pradesh

The company is looking for a site of about 10,000 square metres and has opened talks with Invest UP, according to a company executive.

Greater Noida: DNA Technology, a Russian maker of molecular diagnostic equipment and reagents, is in advanced talks to set up a manufacturing unit in Uttar Pradesh that would be its first production facility outside Russia, a company representative told Moneycontrol.

Sergey Labutin, head of the company’s international sales department, said on the sidelines of the Uttar Pradesh International Trade Show that the firm is searching for a site of around 10,000 square metres. That is roughly half the size of its manufacturing footprint in Russia, which exceeds 20,000 square metres. The planned unit would produce diagnostic equipment and reagents locally, according to the report.

The company has begun negotiations with Invest UP and is assessing possible locations for the plant. Labutin said the team plans to visit the medical park to inspect space, and described Uttar Pradesh and the Noida region as offering significant potential for its manufacturing plans.

The state is developing a 350-acre Medical Device Park near the upcoming Noida International Airport. The park is meant to draw manufacturers of medical devices, diagnostics and precision-engineered products and includes common testing infrastructure, the report said.

DNA Technology already has a branch and business operations in India but does not manufacture in the country. Founded in 1993, it develops and makes polymerase chain reaction (PCR) equipment, diagnostic reagent kits and laboratory solutions. Local production would allow it to participate more deeply in the Make in India programme, according to the company representative.

The company’s India plans have gathered pace in recent months. An Indian delegation visited its production facility in July, and the firm took part in the first INNOPROM industrial exhibition held in India earlier in September, the report said.

Labutin said the size of the Indian market was a key reason for weighing local manufacturing, adding that a sizeable production base in the country could help the company grow its wider international business as well as its Indian operations. “We consider India as a big market for us,” he said.

Source: Moneycontrol, 28 September 2026

  • Related Posts

    Sandur Manganese enters medical devices with wholly owned unit Royal Sandur MedTech

    The mining company has put Rs 1 crore into the new subsidiary, which will make, assemble and distribute medical devices, surgical and diagnostic products and healthcare consumables. Bengaluru: Sandur Manganese…

    DTAB recommends licence exemptions for home-use medical devices and first-aid kits: Report

    Imported first-aid kits meant only for workplace use in sectors such as automobiles and hospitality could skip import licensing if they carry at least 60% residual shelf life. New Delhi:…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

    NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

    ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

    ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

    Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

    Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

    Medicines that cure Us are making Our Environment Sick

    Medicines that cure Us are making Our Environment Sick

    ZEN- G packs a punch in Organ Donation as Over 500 Students pledge Organs

    ZEN- G packs a punch in Organ Donation as Over 500 Students pledge Organs

    PGIMS recalls drug amid probe into deaths

    PGIMS recalls drug amid probe into deaths